News & Events about Accolade Inc.
Ticker Report
2 months ago
Accolade (NASDAQ:ACCD Get Rating) had its price target increased by Bank of America from $12.50 to $14.50 in a research report report published on Tuesday, The Fly reports. Bank of America currently has a neutral rating on the stock. Several other research analysts have also weighed in on ...
Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem PR Newswire SEATTLE, March 6, 2023 Accolade and Lyra will offer employers purpose-built integrations that help address barriers to behavioral health care SEATTLE, March 6...
Globe Newswire
3 months ago
Co-founder of Concur joins Board after serving as the Companys CIOSEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will step down from his operating role at ...
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care PR Newswire OAKLAND, Calif., Jan. 30, 2023 The nonprofit health...
Globe Newswire
4 months ago
SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the 25th Annual Needham Growth Conference on Wednesday, January 11, 2023 and will host a fireside chat at 1:30 pm ET. A webcast and replay of the fireside chat will be available at ir...